BLBC consists of about 10–15% of all breast cancer types, characterized by high proliferation and invasion, high expression of basal cytokeratins (CKs) and low expression of the estrogen receptor (ER), progesterone receptor (PR) and HER2 [ref. 7–10]. This evidence concerns the gene ERBB2 and breast carcinoma.